Cargando...
Impact of HPV vaccination with Gardasil® in Switzerland
BACKGROUND: Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11–14 year-old schoolgirls in Switzerland since 2008. To evaluate its success and its potential impact on cervical cancer screening, HPV genotypes were ex...
Guardado en:
| Publicado en: | BMC Infect Dis |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5741926/ https://ncbi.nlm.nih.gov/pubmed/29273004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2867-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|